Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles

Pharmaceutical Research

Volumn 22, Issue 11, 2005, Pages 1821-1828

  Koziara, J M ^a   Oh, J J ^a   Akers, W S ^a   Ferraris, S P ^b   Mumper, R J ^a  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Blood clotting; Hemocompatibility; Platelet activation; Platelet aggregation; Platelets; Red blood cell lysis

Indexed keywords

HEMOGLOBIN; HEXADECANOL; MACROGOL; NANOPARTICLE; POLYSORBATE;

ARTICLE; BLOOD CELL; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD COMPATIBILITY; CALCULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG FORMULATION; FLOW CYTOMETRY; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

BIOCOMPATIBLE MATERIALS; DRUG CARRIERS; FATTY ALCOHOLS; FLOW CYTOMETRY; HEMOLYSIS; HUMANS; NANOSTRUCTURES; PARTICLE SIZE; PLATELET ACTIVATION; PLATELET AGGREGATION; POLYETHYLENE GLYCOLS; POLYSORBATES; WHOLE BLOOD COAGULATION TIME;

EID: 27144525821     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-005-7547-7     Document Type: Article

References (33)

1. J. Kreuter 1996 Nanoparticles and microparticles for drug and vaccine delivery J. Anat. 189 Pt 3 503 505
2. P. R. Lockman R. J. Mumper M. A. Khan D. D. Allen 2002 Nanoparticle technology for drug delivery across the blood-brain barrier Drug Dev. Ind. Pharm. 28 1 13
3. A. K. Gupta M. Gupta 2005 Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications Biomaterials 26 3995 4021
4. A. K. Gupta A. S. Curtis 2004 Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture J. Mater. Sci. Mater. Med. 15 493 496
5. A. Brownlie I. F. Uchegbu A. G. Schatzlein 2004 PEI-based vesicle-polymer hybrid gene delivery system with improved biocompatibility Int. J. Pharm. 274 41 52
6. I. Constantinescu E. Levin M. Gyongyossy-Issa 2003 Liposomes and blood cells: a flow cytometric study Artif. Cells Blood Substit. Immobil. Biotechnol. 31 395 424
7. R. L. Juliano M. J. Hsu D. Peterson S. L. Regen A. Singh 1983 Interactions of conventional or photopolymerized liposomes with platelets in vitro Exp. Cell Res. 146 422 427
8. R. Male W. E. Vannier J. D. Baldeschwieler 1992 Phagocytosis of liposomes by human platelets Proc. Natl. Acad. Sci. USA 89 9191 9195
9. L. W. Reinish M. B. Bally H. C. Loughrey P. R. Cullis 1988 Interactions of liposomes and platelets Thromb. Haemost. 60 518 523
10. G. Zbinden H. Wunderli-Allenspach L. Grimm 1989 Assessment of thrombogenic potential of liposomes Toxicology 54 273 280
11. L. M. Pinto R. Pereira E. de Paula G. de Nucci M. H. Santana J. L. Donato 2004 Influence of liposomal local anesthetics on platelet aggregation in vitro J. Liposome Res. 14 51 59
12. M. Miyamoto S. Sasakawa T. Ozawa H. Kawaguchi Y. Ohtsuka 1989 Platelet aggregation induced by latex particles. I. Effects of size, surface potential and hydrophobicity of particles Biomaterials 10 251 257
13. M. Miyamoto S. Sasakawa T. Ozawa H. Kawaguchi Y. Ohtsuka 1990 Mechanisms of blood coagulation induced by latex particles and the roles of blood cells Biomaterials 11 385 388
14. J. M. Koziara P. R. Lockman D. D. Allen R. J. Mumper 2003 In situ blood-brain barrier transport of nanoparticles Pharm. Res. 20 1772 1778
15. J. M. Koziara P. R. Lockman D. D. Allen R. J. Mumper 2004 Paclitaxel nanoparticles for the potential treatment of brain tumors J. Control. Release 99 259 269
16. P. R. Lockman J. M. Koziara R. J. Mumper D. D. Allen 2004 Nanoparticle surface charges alter blood-brain barrier integrity and permeability J. Drug Target. 12 635 641
17. M. O. Oyewumi R. A. Yokel M. Jay T. Coakley R. J. Mumper 2004 Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice J. Control. Release 95 613 626
18. M. O. Oyewumi R. J. Mumper 2002 Gadolinium-loaded nanoparticles engineered from microemulsion templates Drug Dev. Ind. Pharm. 28 317 328
19. S. Shalel S. Streichman A. Marmur 2002 The mechanism of hemolysis by surfactants: effect of solution composition J. Colloid Interface Sci. 252 66 76
20. C. Chouly L. Bordenave R. Bareille V. Guerin A. Baquey D. Pouliquen C. Baquey P. Jallet 1994 In vitro study of the hemocompatibility of superparamagnetic contrast agent for magnetic resonance imaging Clin. Mater. 15 293 301
21. C. M. Jackson Y. Nemerson 1980 Blood coagulation Annu. Rev. Biochem. 49 765 811
22. T. Matsuda H. Takano Y. Taenaka K. Hayashi T. Nakamura 1981 Role of surface charge on blood coagulation Polym. Preprints Jpn. 30 1668 1671
23. A. L. Colpey 1977 Platelets and physiological defense mechanism G. Gaetano S. Garattini Platelets. A Multidisciplinary Approach Raven Press New York 161 197
24. Y. Ozaki 1998 Measurements of platelet aggregation and attempts for standardization Sysmex J. Int. 8 15 22
25. F. Ahmed P. Alexandridis H. Shankaran S. Neelamegham 2001 The ability of poloxamers to inhibit platelet aggregation depends on their physicochemical properties Thromb. Haemost. 86 1532 1539
26. R. Gref M. Luck P. Quellec M. Marchand E. Dellacherie S. Harnisch T. Blunk R. H. Muller 2000 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloids Surf., B Biointerfaces 18 301 313
27. H. Otsuka Y. Nagasaki K. Kataoka 2003 PEGylated nanoparticles for biological and pharmaceutical applications Adv. Drug Deliv. Rev. 55 403 419
28. D. Bazile C. Prud'homme M. T. Bassoullet M. Marlard G. Spenlehauer M. Veillard 1995 Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system J. Pharm. Sci. 84 493 498
29. H. Fujii S. Fujii H. Togashi M. Yoshioka K. Nakai H. Satoh I. Sakuma O. Kenmotsu A. Kitabatake 2000 Attenuation of hypothermia-induced platelet activation and platelet adhesion to artificial surfaces in vitro by modification of hemoglobin to carry S-nitric oxide and polyethylene glycol Thromb. Res. 100 519 528
30. M. Amiji K. Park 1993 Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and heparin for reduced thrombogenicity J. Biomater. Sci., Polym. Ed. 4 217 234
31. C. Pan J. Wang H. Sun P. Yang Y. Leng J. Chen G. Wan N. Huang 2004 Research of plasma adsorption and action of platelet adhesion of Dacron modified by plasma surface modification Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 21 536 540
32. J. E. Burchenal C. R. Deible T. E. Deglau A. J. Russell E. J. Beckman W. R. Wagner 2002 Polyethylene glycol diisocyanate decreases platelet deposition after balloon injury of rabbit femoral arteries J. Thromb. Thrombolysis 13 27 33
33. R. Male D. G. Moon J. S. Garvey W. E. Vannier J. D. Baldeschwieler 1993 Organ distributions of liposome-loaded rat platelets Biochem. Biophys. Res. Commun. 195 276 281